GSK China HR Head Victor Gu Departs Amid Series of Executive Leadership Changes
GSK
Pharmaceutical R&D Manufacturer
Recently, GSK announced a personnel update in its management team,GSK China HR Head Victor Gu to Leave GSK, seeking external development opportunities, with the last working day on June 23.
GSK has not yet announced a successor, and during the transition period, Rosalind Sheng, Head of Talent, Leadership and Organization Development (TLOD) at GSK China, will serve as the interim HR head for GSK China.
Anthea Meng, Vice President of Human Resources for GSK Greater China and Intercontinental Region, and Cecilia Qi, Vice President of GSK and General Manager of GSK China, acknowledged Gu Hao's contributions over the past two years in leading the HR team to support GSK China’s business transformation, and wished him success in his new career.
In the past six months, several senior executives of GlaxoSmithKline PLC. (GSK) have changed.On May 9, 2024, Qi Xin, the current Vice President of GSK and General Manager of China, was appointed as the Vice President of Greater China and Intercontinental Regions and Head of Vaccines Business. Yu Hui-ming, Vice President and General Manager of Taiwan, will succeed her as Vice President and General Manager of China.The two officially handed over on June 1 and assumed their new positions on July 1, respectively.Heavyweight! GSK China Changes Leadership
In addition, the personnel changes include: Yu Jinyi, former vice president and head of specialty medicines business, transitioning to the role of vice president and head of respiratory business; Deng Qiao, former national sales director of Benlysta, leaving GSK and being succeeded by Mao Jianjun from the vaccine division; Zhai Tingting, former core business, anti-infective, and R&D finance director, appointed as the compliance head for China.
